ORKA

Oruka Therapeutics
ORKA

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $4.53M invested in Oruka Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

0.19% more ownership

Funds ownership: 0.69% → 0.88% (+0.19%)

96% less call options, than puts

Call options by funds: $18K | Put options by funds: $419K

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$18K
Puts
$419K
Net Calls
Net Calls Change

Top Buyers

1
+$922K
2
+$55.5K
3
+$49K
4
Millennium Management
Millennium Management
New York
+$47K
5
MA
Minerva Advisors
Pennsylvania
+$30K

Top Sellers

1
-$68.7K
2
-$49K
3
-$38K
4
UBS Group
UBS Group
Switzerland
-$19K
5
BlackRock
BlackRock
New York
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.31M
2
$1.24M
3
$795K
4
$326K
5
$282K
6
$207K
7
$96K
8
$86K
9
$52K
10
$49K
11
$47K
12
$30K
13
$7K
14
$4K
15
$1K
16
–
17
–
18
–